Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
151,803,139
-
Total 13F shares
-
148,178,882
-
Share change
-
-4,701,169
-
Total reported value
-
$1,726,248,551
-
Put/Call ratio
-
15%
-
Price per share
-
$11.65
-
Number of holders
-
240
-
Value change
-
-$46,396,284
-
Number of buys
-
138
-
Number of sells
-
88
Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q2 2025
As of 30 Jun 2025,
Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by
240 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
148,178,882 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, BlackRock, Inc., VANGUARD GROUP INC, Rubric Capital Management LP, Sumitomo Mitsui Trust Group, Inc., Nikko Asset Management Americas, Inc., ARK Investment Management LLC, BRAIDWELL LP, AMERIPRISE FINANCIAL INC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
240
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.